| Serial Number | 97625784 |
| Word Mark | INHIBIKASE |
| Filing Date | Monday, October 10, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 4, 2024 |
| Registration Number | 7409853 |
| Registration Date | Tuesday, June 4, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 17, 2023 |
| Goods and Services | Pharmaceutical preparations for the treatment of neurodegenerative disease and cancer |
| Goods and Services | Pharmaceutical research and development; medical and scientific research and development; scientific laboratory services; scientific and technological services, namely, pre-clinical and clinical scientific evaluation in the fields of neurodegenerative disease, cancer and biological research |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 25, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | Wednesday, April 27, 2022 |
| First Use In Commerce Date | Wednesday, April 27, 2022 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 25, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, January 31, 2024 |
| First Use In Commerce Date | Wednesday, January 31, 2024 |
| Party Name | Inhibikase Therapeutics, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Atlanta, GA 30339 |
| Party Name | Inhibikase Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Atlanta, GA 30339 |
| Party Name | Inhibikase Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Atlanta, GA 30339 |
| Event Date | Event Description |
| Thursday, October 13, 2022 | NEW APPLICATION ENTERED |
| Monday, August 28, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, October 25, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, July 24, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, July 25, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 25, 2023 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 25, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, August 28, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, August 29, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, September 8, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, September 8, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Friday, September 8, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, September 8, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Friday, September 8, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 27, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 17, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 17, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 12, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, April 2, 2024 | USE AMENDMENT FILED |
| Tuesday, April 2, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Monday, April 22, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Monday, April 22, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| Monday, April 29, 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Monday, April 29, 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, June 4, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 4, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |